EGF Protein (AA 974-1026)
Quick Overview for EGF Protein (AA 974-1026) (ABIN2017760)
Target
See all EGF ProteinsProtein Type
Biological Activity
Origin
Source
Purity
-
-
Protein Characteristics
- AA 974-1026
-
Characteristics
- ED50 < 0.1 ng/mL, measured in a cell proliferation assay using 3T3 cells.
-
Endotoxin Level
- < 0.2 EU/μg, determined by LAL method.
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstituted in ddH2O or PBS at 100 μg/mL.
-
Buffer
- Lyophilized after extensive dialysis against PBS.
-
Storage
- -80 °C
-
Storage Comment
- Lyophilized recombinant Rat Epidermal Growth Factor remains stable up to 6 months at -80 °C from date of receipt. Upon reconstitution, Rat Epidermal Growth Factor should be stable up to 1 week at 4 °C or up to 2 months at -20 °C.
-
Expiry Date
- 6 months
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Background
-
Epidermal Growth Factor, a low-molecular-weight polypeptide, is the founding member of the EGF-family of proteins. It can be found in platelets, macrophages, urine, saliva, etc. EGF acts by binding with high affinity to the Epidermal Growth Factor Receptor (EGFR) and stimulating downstream protein tyrosine kinase activity. This signal transduction cascade results in increased intracellular calcium levels and increased rates of glycolysis and protein synthesis. EGF stimulates the growth of many epidermal and epithelial tissues. Pharmaceutical drugs designed to inhibit EGFR have been used to treat certain types of cancer.
Synonyms: Epidermal Growth Factor, Urogastrone, URG -
Molecular Weight
- 6 kDa, observed by reducing SDS-PAGE.
-
UniProt
- P07522
-
Pathways
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Target
-